A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT06126237 · UNKNOWN
Trial details
- NCT number
- NCT06126237
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-28
- Primary completion
- 2026-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.